Skip to ContentSkip to Navigation
How to find us R.W.K. (Robbert) Borgemeester


EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

Cutaneous adverse drug reaction after apomorphine infusion, possibly caused by a systemic type IV hypersensitivity reaction to sodium metabisulfite: Report of 2 cases

Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study

Graphical Tasks to Measure Upper Limb Function in Patients With Parkinson's Disease: Validity and Response to Dopaminergic Medication

Histology of subcutaneous nodules in PD patients treated with continuous apomorphine infusion: Case series and review of the literature

Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients

Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence

The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine

Long-term data on subcutaneous apomorphine in Parkinson's disease patients; a retrospective analysis of a Dutch cohort of 139 patients

Read more